Stage IIIC Uveal Melanoma AJCC v7 Completed Phase 2 Trials for Dacarbazine (DB00851)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0106952 (Stage IIIC Uveal Melanoma AJCC v7) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01835145 | Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery | Treatment |